Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06713668 · ClinicalTrials.gov registry record · NA
Augmented Pacing for Shock in the Cardiac Intensive Care Unit
A NA study of Bradycardia and Cardiogenic Shock, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06713668: Recruiting NA study of Bradycardia and Cardiogenic Shock, sponsored by Vanderbilt University Medical Center.
NCT06713668 is a NA study of Bradycardia and Cardiogenic Shock that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 25 participants, below the 4,412-participant average among 29 other Bradycardia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06713668, a NA study of Bradycardia and Cardiogenic Shock, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if backup pacing at an increased rate improves hemodynamics in adults with relative bradycardia, a permanent pacemaker, and cardiogenic shock. The main question it aims to answer is: Does increasing the backup pacing rate to 100 beats per minute lead to improved cardiac index compared to a backup pacing rate of 75 beats per minute Participants who are already hospitalized in the Cardiovascular Intensive Care Unit with a permanent pacemaker and pulmonary artery catheter in place will be enrolled in this study. Participants will be exposed to each pacemaker rate in a randomized order with hemodynamics assessed after 10 minutes at each rate.
Primary Outcome
Cardiac Index measured by thermodilution (in liters per minute per meters squared)
Conditions Studied
Interventions
- DEVICE Backup Pacing Rate Change
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-04-22 |
| Est. Completion | 2027-04-22 |
| Phase | NA |
What NCT06713668 shows while recruiting
NCT06713668 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 4,412-participant average among 29 other Bradycardia trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Backup Pacing Rate Change is the first listed.
NCT06713668 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06713668 about?
NCT06713668 is a clinical study titled "Augmented Pacing for Shock in the Cardiac Intensive Care Unit". The goal of this clinical trial is to learn if backup pacing at an increased rate improves hemodynamics in adults with relative bradycardia, a permanent pacemaker, and cardiogenic shock. The main question it aims to answer is: Does increasing the backup pacing rate to 100 beats per minute lead to i...
What is the current status of trial NCT06713668?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-04-22. Estimated completion is 2027-04-22.
What conditions does trial NCT06713668 study?
This clinical trial studies the following conditions: Bradycardia, Cardiogenic Shock, Shock.
What interventions are being tested in trial NCT06713668?
The interventions under investigation include: Backup Pacing Rate Change (DEVICE).
Who is sponsoring clinical trial NCT06713668?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06713668 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bradycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06713668's enrollment target sits among peer trials
25 29th of 29 higher than 1 of 29 other Bradycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bradycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
ACTIVE NOT RECRUITING · NA
-
Aveir DR i2i Study
ACTIVE NOT RECRUITING · NA
-
The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
ACTIVE NOT RECRUITING · NA
-
EMRI SureScan™ Clinical Study
COMPLETED · NA
-
ECG Belt to Assess Electrical Synchronization
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI